Dongxuan Li

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Breast Cancer Risk

Electronic Health Record

Top Venues

Expert opinion on drug safety

Journal of clinical pharmacy and therapeutics

Clinical pharmacology and therapeutics

Therapeutic advances in drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Dongxuan Li, Chunmeng Qin, Hongli Wang, Dan Du, Yalan Wang, Qian Du, Songqing Liu
Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database. Therapeutic advances in drug safety 15 (2024)
Dongxuan Li, Liyang Dai, Jun Zhu, Yalan Wang, Rui Zhang, Fan Wu, Tongyan Zhang, Songqing Liu, Qian Du
Drug-induced erectile dysfunction: a real-world pharmacovigilance study using the FDA adverse event reporting system database. Expert opinion on drug safety (2024)
Dongxuan Li, Liyang Dai, Jun Zhu, Yalan Wang, Rui Zhang, Fan Wu, Tongyan Zhang, Songqing Liu, Qian Du
Drug-induced erectile dysfunction: a real-world pharmacovigilance study using the FDA adverse event reporting system database. Expert opinion on drug safety (2024)
Dongxuan Li, Hongli Wang, Chunmeng Qin, Dan Du, Yalan Wang, Qian Du, Songqing Liu
Drug-induced Acute Pancreatitis: A Real-world Pharmacovigilance Study Using the FDA Adverse Event Reporting System Database. Clinical pharmacology and therapeutics (2023)
Dongxuan Li, Jinghui Gou, Jie Dong, Yuzhu Dong, Xin Xi, Cheng Chen, Qian Du, Songqing Liu
Asparaginase-related diabetic ketoacidosis: Analysis of the FDA Adverse Event Reporting System (FAERS) data and literature review. Journal of clinical pharmacy and therapeutics (2022)